-
Colombian judge bans strikes on guerrillas if minors are present
-
Carreras reverts to fullback as Argentina change four for Australia Test
-
Khachanov shocks ailing Auger-Aliassime, Swiatek and Osaka advance at US Open
-
Wilson back to lead Australia as Kiss rotates team for Argentina
-
Lone juror blocking verdict in US mother's child murder trial: defense
-
Yen surges on new intervention talk, US stocks rally
-
'Kinda chic' - Williams sisters set to launch US Open doubles bid
-
Japan's Ueda fires Lille top of Ligue 1 on debut
-
Volkswagen says cutting 100,000 jobs by end of decade
-
Arsenal chief executive reveals 'dynasty' ambition
-
Russia slaps curfew on charity director over army criticism
-
Spanish PM says no 'solid proof' Morocco planned migrant rush
-
Ailing Auger-Aliassime upset by Khachanov at US Open
-
Iran war is not a war, US VP Vance says
-
Richarlison omitted from Tottenham's Premier League squad
-
Khachanov stuns third-seeded Auger-Aliassime in US Open second round
-
How El Nino is choking the Panama Canal
-
Bordeaux facing sixth-tier football after French federation upholds relegation
-
Hamilton drives his Ferrari dream at Monza
-
Stoic Verstappen looking beyond 'painful' Monza weekend
-
Senegal has an IMF loan, now what?
-
OpenAI begins rollout of new powerful AI model GPT-6 Astra
-
Auger-Aliassime upset by Khachanov at US Open
-
FIFA blasts UEFA 'smear campaign,' fights World Cup plan disclosures
-
Hugging Face, the French start-up that became AI's warehouse
-
Zelensky hopes to host US envoys in Kyiv in 'coming days'
-
World Cup winner Llorente retires from Spain team at 31
-
Martinelli joins Al-Hilal from Arsenal for reported £60 million
-
Osaka squeezes into US Open third round
-
Tesla's semi-autonomous driving could be adapted to EU norms: France
-
Apple faces £2 bn lawsuit in UK over app privacy feature
-
37 people die from fumes during oil pipeline theft in Nigeria: NGO
-
Former champ Swiatek eases into US Open third round
-
Ahead of elections, Israel tests West's patience on West Bank violence
-
DR Congo latest to promise moving Israel embassy to Jerusalem
-
Antonelli will obey Mercedes orders to help 'tow' teammate Russell
-
War criminal Mladic's body returns to Serbia with military honours
-
UK fintech Revolut gains conditional US banking licence
-
Pierre Cardin museum brings designer's futurist style to Venice
-
Mara sisters channel childhood energy for twins performance at Venice
-
Slovenian rookie Omrzel triumphs as Mas extends Vuelta lead
-
UN's Sudan probe says foreign fighters fuelling conflict
-
British, French leaders talk migrants, EU relations
-
Violence erupts at S.Africa anti-migrant protest
-
Heading for Ferrari's home race, Leclerc still dreams of world title
-
Nothing left: Nepal flood survivors face loss and uncertainty
-
Cafe at centre of Israel culture clash agrees to shut on Sabbath
-
Tesla to launch self-driving 'Cybercab' in Texas
-
Spacecraft bound for Mercury begins 'tricky' arrival
-
Europe struggles to respond as Russia escalates shadow warfare
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
BELGRADE, MT / ACCESS Newswire / February 28, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2024, after the close of the financial markets on Thursday, March 6, 2025.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Thursday, March 6, 2025 at 4:30 PM ET to review results.
Conference Details:
Conference Date: Thursday, March 6, 2025
Conference Time: 4:30 PM ET
Conference dial-in: 888-506-0062
International dial-in: 973-528-0011
Passcode: 907938
Conference Call Name: Xtant Medical Q4 and Year End 2024 Financial Results
Webcast Link: https://www.webcaster4.com/Webcast/Page/3039/52116
Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor Info."
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
Brett Maas • Managing Partner, Hayden IR
[email protected] • (646) 536-7331
SOURCE: Xtant Medical Holdings, Inc.
View the original press release on ACCESS Newswire
R.Garcia--AT